Article Text

Download PDFPDF

Author index

Statistics from

Aalbers CJ et al. Improvement of rAAV5 transduction efficiency in fibroblast-like synoviocytes by doxorubicin, A46

Aarrass S A110, A171

Abbate R A87

Abreu JRF A40

Abreu JRF et al. Maintenance of T cell Rap1 signalling protects mice against collagen-induced arthritis, A66

af Klint E A58

Agmon-Levin N A156, A20

Água-Doce AM A166

Åhlin E A15

Åhlin E et al. SSA and SSB antibodies are important in the formation of circulating immune complexes in SLE, A6

Airò P A22

Akhmetshina A A66, A64

Aksentijevich I A72

Alard J-E A105

Al-Edreese M A15

Aleixo I A51

Alemayehu WG A18

Alemo-Munters L A158

Alexander T et al. Identification of cellular markers predicting relapses after immunoablation and autologous haematopoietic stem cell transplantation (ASCT) for refractory systemic lupus erythematosus, A52

Alissafi T A136

Allanore Y A162

Amaral PM A51

Ambarus C A103

Ambarus CA A33

Anaja J-M A20

Andersone D A100

Andersson U A94, A94

Antal P A181

Antoniou M A144

Apparailly F A153, A86, A153

Arajs J A100

Arnold R A132

Arntz OJ et al. Chondrocytes from arthritic cartilage in a subset of osteoarthritis patients express lower levels of nfκB-p65: a survival factor against tumour necrosis factor α-induced cell death, A18

Asmawidjaja PS A173, A183

Asnagli H A179

Asquith DL A101

Asquith DL et al. Apoe-deficient mice are resistant to the development of collagen-induced arthritis, A54

Assier E et al. IL-23 specific targeting by active immunisation improves inflammation and destruction in a murine model of rheumatoid arthritis, A46, VEGF targeting by active immunisation improves joint inflammation and destruction in a murine model of rheumatoid arthritis, A46

Astica I A100

Astorri E A31

Audo R et al. Regulation of pleitropic effect of TRAIL on RAFLS by TRAIL-R1 and -R2, A56

Aveberger A A94

Avouac J et al. Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis, A64

Axmann R A29

Baas F A81

Babos F A2

Bader M A64

Baeten D A147, A103, A147

Baeten DL A103, A180, A103

Baeten DLP A81

Baka Z et al. Immune cell-derived microparticles in polymyositis/dermatomyositis, A55

BalaguéF A140

Ballantine L A73

Bannoudi H A187

Barak V A156

Barendregt B A147

Baron M A67

Barone F A31

Barzilai O A20

Basel-Duby R A49

Baum W A42, A42

Baumann C A151

Baumgrass R A164

Bax M et al. Targeting Siglec-E on murine dendritic cells inhibits antigen presentation and CD4 and CD8 T cell responses, A42

Beaten D A49

Belmonte N A179

Benedetti F A61

Benelli G A161

Bennink MB A46

Bernier E A116

Bertrand J A49, A104

Bertrand J. et al. The bacterial effector protein YopM is a self-delivering immune therapeutic agent that reduces inflammation in rheumatoid arthritis, A47

Bertsias G A68

Bessis N A116

Betrand J A114

Bettelli E A180

Bianchi ME A1

Biasi D A61

Biesen R A132

Binder N A169

Blanco FJ A143, A143

Blank M A20

Blom A A102

Blom AB A102

Blüml S A131

Blüml S et al. Analysis of TNFR2-mediated functions on osteoclast precursor cells, A35

Böhm C A29

Böhm C et al. ERK-activated kinase RSK2 protects against inflammatory arthritis-induced bone destruction by opposing the tumour necrosis factor α-mediated inhibition of bone formation, A24

Boileau C A162

Boissier MC A116

Bombardieri M et al. Molecular and cellular evolution of functional tertiary lymphoid structures in salivary glands of NOD mice, A12

Bombardieri S A161

Bonelli M A131

Bonelli M et al. Effects of abatacept on monocytes in patients with rheumatoid arthritis, A67

Bonnefont A-L A179

Boon L A136, A173

Borchardt T A55

Bos C A37

Bos WH A13

Boumans M A37

Boumpas D A89, A136

Boumpas DT A71, A177, A68, A72

Braem K et al. Involvement of chemokines in the spontaneous ankylosis mouse model: further evidence for the ‘entheseal stress’ hypothesis, A17

Brembilla NC A188

Brizzolara R A78

Broder A, Putterman C. The effects of hydroxychloroquine on antiphospholipid antibody titres in SLE, A10

Broen J et al. Skewed X-chromosomal inactivation patterns are present in systemic sclerosis and associated with FOXP3 expression, A30

Brouard S et al. Modulation of humoral immune responses as a novel mechanism of action of tumour necrosis factor blockade, A58

Bruns A A27

Bruyer A A142

Brys R A157

Buckner JH A185

Bulina I et al. Tumour necrosis factor α in rheumatoid arthritis and osteoarthritis patients in blood serum and synovial fluid, A40

Burakowski T A174

Bürgis S A48

Burkhardt H A113, A24

Burmester G A8

Burmester G-R A132, A27, A109

Busch N A64, A64

Buttgereit F A27

Buzás E A141

Buzás EI A3, A181

Byrne R A160, A131

Caetano-Lopes J A130

Caetano-Lopes J et al. Bone cell activity influences bone fragility and fracture risk, A20

Calmon Hamaty F et al. Lymphotoxin α stimulates proliferation and proinflammatory cytokine secretion of rheumatoid arthritis fibroblast-like synoviocytes, A61

Canete J A103

Canhão H A139, A128, A128, A130

Cantaert T A180, A81, A103, A147

Cantaert T et al. Detection of genuine anti-citrullinated protein antibodies in mice reveals their presence in BALB/c but not DBA/1 and SJL mice hyperimmunised with citrullinated collagen, A5, Elevated levels of CD5+ B cells in spondyloarthritis patients, A13

Carter S A44

Cascão R A128, A130

Cascão R et al. Cytokine network in the first 6 weeks of rheumatoid arthritis onset, A50

Catrina AI A10, A58

Cavazzana I A22

Cazalis M-A A112

Cefle A A77

Cerezo L A141

Ceribelli A et al. Anti-argonaute 2 (Ago2/Su) and -Ro antibodies are the common autoantibody specificities in primary anti-phospholipid syndrome (PAPS), A3, Anti-Th/To antibodies in italian scleroderma patients: clinical and immunological correlations and comparison with patients with anti-centromere antibodies, A9

Cetin E A160

Chan EKL A22

Chan JYF A22

Chang H-D A164

Charbonney E A21

Charles PJ et al. Myositis associated autoantibodies detected using a novel recombinant protein blotting: clinical associations, A9

Chen W A164

Chicheportiche R A4 A188

Chizzolini C A188

Choi SJ A108

Chorazy-Massalska M et al. Interleukin 15 triggers differentiation/maturation of Foxp3+ T cells from bone marrow in indoleamine 2,3-dioxygenase (IDO)-dependent manner, A69

Choulaki C et al. Rheumatoid arthritis (RA) patients have variable but comparable NLRP3-inflammasome induction to controls, A36

Choustoulaki E A89, A68

Christianson CA et al. Persistent tactile allodynia and spinal glia activation in the K/BxN serum transfer arthritis model, A53

Churchman S A170

Cidon MJ. The script concordance test in paediatric rheumatology (SCT-PR): a novel tool to assess clinical reasoning competence, A64

Clavel C A5

Clemessy M A162

Coates L A170

Coenen MJ A75

Colato C A61

Colin EM A183

Combe B A142, A154

Conaghan PG A170

Cope A A8

Cornelissen F A173

Corneth OBJ A183

Corr M A135

Corrigall V A53

Corrigall VM A144

Corscadden D A170, A172

Corsiero E A31

Corvol P A162

Cosan F et al. A novel TNFRSF1 gene mutation in a turkish family: report of three cases, A31

Courties G A153

Courties G et al. A liposome-based nanocarrier for preferential targeting of the mononuclear phagocyte system in arthritic mice, A60

Creusot RJ A150

Crocker PR A106

Cromme C et al. Inflammatory tissue damage in chronic destructive arthritis is regulated by FHL2, A19

Crow MK A93, A37

Cuthbert R A172

Cuthbert R et al. Reduced interleukin 7 serum titres are associated with progression towards rheumatoid arthritis in very early inflammatory arthritis, A68, Severity of T cell subset dysregulation influences the probability of achieving drug-induced remission in early arthritis, A67

Cutolo M A78

Cutolo M et al. Imaging and rheumatic diseases: correlation between fingertip blood perfusion and nailfold capillary impairment in systemic sclerosis, A49

Daha NA A16

Daïen C A83

Daïen CI et al. Single nucleotide polymorphism 25-TGFβ1 as a possible marker of response to rituximab in rheumatoid arthritis, A34

Daïen V A83

Dalwigk K A160

Damotte D A116

Dankbar B A114, A114

Dankó K A23, A156

Dass S A172

David J-P A29, A53

Dayer J-M A4, A188

de Koning M A13

de Launay D A123, A41

de Launay D et al. Selective involvement of ERK and JNK MAP kinases in the synovial tissue of patients with early arthritis, A16, Silencing expression of Ras family GTPase homologues decreases inflammation and joint destruction in experimental arthritis, A16

de Man YA A159, A107

De Marchis F A1

de Rijke YB A159

De Rycke L A147

De Rycke LE A103

de Steenwinkel FDO et al. Are circulating proinflammatory cytokines associated with lower birth weight of newborns from women with rheumatoid arthritis?, A63

de Vries I A115

de Vries N A81

de Vries RRP A187, A16

de Vries TJ A102, A54

Dechant C A165

Deelder AM A107

Dees C A64

Dees C et al. 5-HT release from platelets and activation of 5-HT2B play a crucial role for development of fibrosis in systemic sclerosis, A26, Promoter hypermethylation of the anti-fibrotic gene SOCS-3 by TGFβ as novel mechanism in the pathogenesis of SSC, A26

Del Galdo F A61

deLaunay D A168

Delavallee L A116

Deraos S A136

Derks IAM A81

Deroose C A44

Devauchelle V A35

Dietrich A A104

Dijkmans BAC A13, A30

Dinarello CA A119

Dinser R A55

Distler JH A42, A24

Distler O A64, A62, A64

Djouad F A105

Dolhain RJEM A159, A107, A183

Dong J A164

Dontje W A168

Doorenspleet ME A81

Dragomir C A93

Dreier R A114

Drennan M A157

Drijfhout JW A187

Dübel S A113

Duroux-Richard I A105, A153

Duvallet E A116

Echtermeyer F A114

Echtermeyer F et al. Syndecan-4 regulates cartilage degradation in osteoarthritis, A23

Eckes B A43

Eddleston A A155

Ekholm L A23

Elagib EM A15

el-Bannoudi H A121

Eldering E A81

Elewaut D A157

Elferink BG A187

Eliopoulos E A72

Eljaafari A et al. Mesenchymal stem cells participate in the loop leading to amplification of inflammation through secretion of interleukin (IL)6, IL1β and IL8, A70

Eloranta M-L A14

Elshafie AI et al. Comparative study between Swedish and Sudanese RA patients, A6

Emery P A170, A172

Ender S A43

Engelke K A29

Englbrecht M A24

Erlandsson Harris H A90, A94

Escriou V A153

Evans HG A182

Everts V A102, A54

Fabian A A104

Fabre S A83, A153

Fall PB A179

Falus A A3, A181

Fang Z A164

Fardellone P A170

Fatini C A161

Faustino A A139

Faustova M et al. Genetic variation in promoter sequence of B cell-activating factor gene is associated with increased risk of myositis development, A31

Feitsma AL et al. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4 positive RA patients, A74

Feldt O A129

Fernandes D A139, A130

Ferner E A131

Ferrari-Lacraz S et al. Upon contact with stimulated T cells, expression of peptidylarginine deiminase 2 and 4 is upregulated in human monocytes, A2

Ferrone C A124

Fiehn C A55

Finckh A A140

Firestein GS A135

Fischer S A137

Floessdorf M A164

Fluiter K A123

Fonseca JE A139, A128, A128, A130

Foulquier C A4

Foussat A A179

Franceschini F A22

Franco Salinas G A147

Franco Salinas G et al. Constitutive co-stimulation by B cells is sufficient to trigger T cell-driven autoimmune disease, A71

Franek BS A80

Frank S A43, A43

Frank S et al. Upregulated SUMO-2/3 expression is involved in the regulation of apoptosis and matrix metalloproteinase expression in rheumatoid arthritis synovial fibroblasts, A30

Franken KLMC A187

Frey B A42

Frommer K et al. Potential adipokine involvement in systemic sclerosis, A25

Fuhrmann F A164

Fürnrohr BG A1, A24

Füst G A3

Gabay C see Genevay S et al, see Lamacchia C et al

Gabba S A31

Gallo F A78

Gansler J A137

Garaud S A34

Garcia-Vallejo JJ A106

Garrison Fathman C A150

Gasc JM A162

Gay S A64, A62

Géher P A3

Genevay S et al. Adalimumab in severe and acute sciatica, A55

Georg Schett HW A64, A64

Georg Schett A64

Gerlag DM A37

Gershwin ME A20

Gessner A A48

Geurts-van Bon L A75

Geyer M et al. Joint regeneration in newts? Yes, they can!, A22

Giacomelli R A161

Gilburd B A156, A20

Gilchrist D A101

Goëb V A170

Gottschal L A81

Goulielmos G A89

Goulielmos GN A72

Goulielmos GN et al. The CD40 region is associated with multiple autoimmune diseases in the greek population, A29

Grabiec AM A168

Graça L A128, A128, A166

Gracie A A101

Gracie JA A73

Graef D A24

Grevers L A102

Grevers LC A54

Grevers LC et al. Immune complex-mediated inhibition of osteoclastogenesis: role for the inhibitory FC γ receptor IIB in bone erosion in antigen-induced arthritis?, A23

Grigoriadis A A53

Grouard-Vogel G A116

Grün J A125, A164

Grün JR A79

Grunke M A165

Grützkau A A79, A125

Guerrier T A105

Guiducci S A161, A161

Gul A A77

Gullick NJ et al. Interleukin 17-producing cells are increased in the peripheral blood of patients with rheumatoid arthritis and are enriched at the site of inflammation, A72

Günther A A62

Gusinde J A64

György B et al. Natural autoantibodies reactive to glycosaminoglycans are disease state markers in rheumatoid arthritis and are associated with HLA, A2

Haftmann C A164

Hahne M A142, A154

Hamann D A13

Hamann J A123

Haslbeck M A24

Häupl T A8, A79, A125

Hayer S et al. Interleukin-6 is not a crucial regulator in tumour necrosis factor-mediated bilateral sacroiliitis, A49

Hazes JMW A159, A107, A183

Hegazy A A164

Heinhuis B et al. IL-32γ and streptococcus pyogenes cell wall fragments synergise for IL-1-dependent destructive arthritis via upregulation of TLR-2 and NOD2, A47

Heinz G A164

Hendriks RW A173

Henshaw K A170, A172

Hensor E A172

Herenius MM A81

Herman S A151

Herman S et al. Apoptosis and the subsequent generation of autoantigens as initial triggers in the pathogenesis of experimental autoimmune arthritis, A60

Hermann K-G A27

Hermann S A48

Herrmann M A1

Herzog C A114

Hess A A29

Heyder P A1

Hiepe F A132, A27

Hilkens CMU A184

Hillion S et al. Intravenous immunoglobulin promotes apoptosis of mature human B lymphocytes by using CD22 to modulate their antigen B cell receptor, A48

Hillmann A A48

Hoek RM et al. Deletion of either CD55 or CD97 ameliorates arthritis, A48

Höfer T A164

Hoffmann M A151

Hoffmann M et al. Heterogeneous nuclear ribonucleoprotein-associated nucleic acids trigger disease in a rat transfer model of arthritis, A40

Hofkens W et al. Systemically delivered glucocorticoid liposomes suppress bone erosion and inhibit osteoclast activation in synovium and bone marrow during experimental murine arthritis, A21

Hokken ACS A159

Horn A A64

Horn A et al. Activation of Hedgehog signalling plays a crucial role in the pathogenesis of systemic sclerosis, A27

Horner EA A170

Hot A et al. Pathogenic role of IL-17 in endothelial dysfunction, a link between rheumatoid arthritis and atherosclerosis, A44

Houwing-Duistermaat JJ A16

Hoyer BF et al. Takayasu's arteritis characterised by disturbances of B cell homeostasis responds to B cell depletion with RITUXIMAB, A11

Hudecz F A2

Hudson M A67

Hueber A A73

Hueber AJ A101

Hueber AJ et al. Alarmin interleukin 33 is overexpressed in psoriasis and induces ST2-dependent psoriasis-like dermatitis, A40

Hügle T et al. Analysis of mononuclear cell subsets in dermis and blood of patients with systemic sclerosis by multicolour flow cytometry, A25

Huijbens R A95

Huijbens RJF A98

Huizinga TWJ A187, A121, A16, A16

Hulejova H A76

Humrich J et al. Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus, A43

Humrich JY A109

Hunter J A73

Ibba-Manneschi L A161

Ibba-Manneschi L et al. Histopathological modifications in haemophilic synovial tissue, A64

Iliopoulos D A68, A72

Innocenti M A161

Ioan-Facsinay A A187, A16, A121

Ioan-Facsinay A et al. Anti-CCP antibodies are a collection of ACPA that are cross-reactive to multiple citrullinated antigens, A8

Ioannou M et al. Plasmacytoid dendritic cells regulate the magnitude of an autoimmune response through expansion of suppressive monocytes, A54

Isaacs JD A184

Jacques P A157

Jahn A A164

Jakobs ME A81

Jakobsson P-J A10

James R A21

Jamin C et al. Anti-ATP synthase autoantibodies alter endothelial cell (EC) survival by disrupting PH regulation in vasculit, A10, Toll-like receptor 9 (TLR9) controls B cell differentiation in salivary glands of patients with Sjögren's syndrome, A42, Toll-like receptor 9 (TLR9) controls B-cell differentiation in salivary glands (SG) of patients with Sjögren's syndrome (SS), A7

Janicka I A174, A134

Jastrzebska M A174

Jastrzebska M et al. Rheumatoid adipose tissue is a potent source of cytokines, A53

Jaunalksne I A100

Jayaraj D A182

Ji JD et al. Regulation of interleukin-1β expression by 1,25-dihydroxyvitamin D3 in human macrophages, A43

Jolly M A80

Jol-van der Zijde CM A16

Joosten L A42

Joosten LAB A119

Jorgensen C A153, A83, A83, A179, A105, A153

Jourdin-Boucard M A179

Jovanonic V A147

Jun J-B A108

Jünge A A64

Kahan A A162

Kalden JR A1

Kardassis D A72

Kariuki SN A80

Karonitsch T et al. IFN-gamma promotes fibroblast-like synoviocytes motility, A63

Karpus O A123

Katz B-SP A20

Kaur Singh S A106

Kavousanaki M et al. Interleukin 21-conditioned dendritic cells promote T cell reactivity through the downregulation of ICOS-L, A70

Keitzer R A27

Kerzendorf U A165

Khalafalla KE A15

Kiener HP A160

Kim AHJ et al. A novel model of murine B cell-mediated proteinuria identical to human minimal change disease, A15

Kim S-H A119

Kim T-H A108

Kim Y A108

Kireva T et al. Proteasome inhibition aggravates tumour necrosis factor-mediated bone resorption, A16

Kirkham BW A182

Kirou KA A37

Kirschning C A1

Kittel Á A141

Kivity S et al. Thyroid disease and vitamin D deficiency, A62

Klarenbeek PL et al. Complete T and B cell receptor repertoire analysis in rheumatoid arthritis using high throughput sequencing, A33, High throughput sequencing (HTS) provides full repertoire analysis of the B and T cell receptors in humans and mice, both in blood and synovial tissue, A33

Klareskog L A10, A185

Klavinskis LS A144

Klevenvall L A94

Klich K A185

Kloke L A109

Kloppenburg M A121

Kny A A151

Koenders M A42

Koenders MI A119

Koenders MI et al. IL-21R deficiency during experimental arthritis increases local expression of inflammatory mediators but protects against joint pathology by suppressing Th17 cells, A73

Kollias G A29, A49, A48, A43, A114, A43

Koncz A A3

Konthur Z A8

Kontny E A174, A134

Kop EN A123

Korb A A49, A43

Korb A et al. The TRAF6 binding molecule p62/SQSTM1 is a critical regulator of inflammatory bone destruction, A19

Korotkova M A133, A129

Kotsakis S A7

Kovalchuk L A100

Krasoudaki E A68

Krausz S A168, A41

Krausz S et al. Macrophage stimulation by angiopoietins-1 and -2 promotes recruitment and retention of white blood cells at sites of inflammation, A37

Kritikos H A71, A68

Krönke G A91

Krystufkova O A76

Kuchroo VK A180

Kurowska-Stolarska M et al. miR-155 and miR-34a regulate proinflammatory cytokine production by human monocytes, A30

Kyriakidis NC A7

Lafyatis R A75

Lamacchia C et al. Production and biological role of hepatocyte and myeloid cell-derived interleukin-1 receptor antagonist in a model of systemic inflammation, A58

Lang V et al. The early marginal zone B cell initiated T independent type 2 response resists the proteasome inhibitor bortezomib, A12

Langerak AW A75

langevitz P A156

Larida B A20

Laurent L et al. Rheumatoid factor amplifies the macrophage secretion of TNFα induced by ACPA-citrullinated fibrinogen immune complexes, A2

Lavrentjevs V A100

Le Blay P et al. Genetic markers in clinical subtype of juvenile idiopathic arthritis, A34

Le Dantec C A34

Le Loët X A170

Le Pottier L A105

Le Pottier L et al. B cell activating factor of the TNF family: δ4BAFF, an alternate-splice isoform that acts as a transcription factor and exaggerates its production in autoimmunity and cancer, A14

Lebre MC A110, A171

Lee B A108

Lee YH A108

Lee YJ A114

Leenen PJM A54

Lefèvre S A137

Lefèvre S et al. Migrating synovial fibroblasts: a homogenous population?, A54

Lehr A A137, A137

Leipe J A165, A189

Leipe J et al. Th17 cells in autoimmune arthritis, A69

Lema B A143, A143

Lems WF A30

Lenief V A112

Li N A164

Liew FY A101, A73

Lin F A123

Linari S A161

Lindemann O et al. Transient receptor potential (TRP) channels contribute to neutrophil chemotaxis during the inflammatory response, A41

Lindroos E A133

Lipsky PE A176

Litjens M A106

Loddenkemper K A27

Loell I A133

Loell I et al. Effects of immunosuppressive treatment on leukotriene pathway in polymyositis and dermatomyositis, A62

Löhning M A164

Loiler SA A115

Lopes A A139

López-Armada MJ A143, A143

Lora M A121

Lories RJ A44

Louis-Plence P A179

Lubberts E A173, A183

Ludwig C A83

Lukitsch I A109

Lund O A181

Lundberg IE A23, A133

Luyten FP A44

Mach F A21

Magyar A A2

Maldyk P A174, A134

Mally S A104

Malmström V A129, A10, A185

Manetti M A161

Manetti M et al. Association between the MMP-12 gene and systemic sclerosis: role of RS2276109 functional polymorphism in the modulation of skin and pulmonary fibrosis, A35

Manfredi AA A1

Mann H A141

Mantello A A179

Marenzana M et al. Differential distribution of a PEGylated Fab' into inflamed versus normal tissue compared with an IgG in arthritis and colitis models, A61

Marijnissen RJ A119

Marijt KA A121

Marklein B et al. JKTBP (HNRNPDL) is a novel TOLL7/9 dependent target in humans and animal models of inflammatory rheumatic diseases, A4, Toll-like receptor (TLR-7/9), MyoD88, Tir8, dependent and independent autoantigens, A39

Martin Jäck H A29

Martire D et al. Single injection of antigen-specific regulatory Tr1 lymphocytes protects mice from severe collagen-induced arthritis, A71

Marzo-Ortega H A170

Masdar H A103

Mashreghi M-F A164

Maslinski W A174, A134

Mathsson L A14, A129

Matsoukas J A136

Matthes T A188

Matucci-Cerini M A20

Matucci-Cerinic M A161, A161

Maza S A27

McGowan N A53

Mcinnes I A42

McInnes IB A101, A101, A73, A133

McKenzie EJ A106

Medof ME A123

Meinecke I A114

Meister S A29, A42, A1

Melchiorre D A161

Melissourgaki M A71

Ménard HA A121

Meyer LH A49

Mielenz D A29, A24

Mikolaitis RA A80

Milia AF A161, A161

Millar NL A101

Miller AM A101, A101

Mingozzi F A115

Miossec P A178, A112

Misják P A3

Mittoo S et al. Predicting lung function decline in systemic sclerosis (SSc), A27

Modesti M A149

Moizant F A147

Molinari N A83

Montagna P A78

Montecucco C A161

Monteiro J A139

Morel J A142, A154

Morfini M A161

Moura R A130

Moura RA A128

Moura RA et al. Cytokine profile in serum and synovial fluid of patients with established rheumatoid arthritis, A51

Mourão AF A128, A128

Müler-Ladner U A137

Mullazehi M et al. Anti-type ii collagen-immune complex-induced production of interleukin 1β and tumour necrosis factor α stimulate production of matrix metalloproteinases from monocyte/rheumatoid arthritis synovial fibroblast co-cultures, A51

Müller C A55

Müller-Ladner U A62, A55, A150, A137

Müller-Schrobsdorff F A55

Mumtaz IM A27

Munoz L A1

Mus AMC A183

Mus AMC et al. Interleukin (IL)23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for IL22 but not IL21 in autoimmune experimental arthritis, A69

Nader G A133

Nagelreiter I A126

Nagy G A141, A3, A181, A2

Nakou M A68

Nam J A170

Näther M A109

Neregård P A58

Nesbitt A A155

Neubert K A42, A29

Neugebauer K A49, A114, A114

Neumann E A62, A137, A150, A137

Newsom-Davis T A171

Nickerson-Nutter C A119

Nicola B A20

Niedereiter B A160

Niedermeier M A104

Niederreiter B A169, A49, A126, A131

Niewold TB A80

Nimmerjahn F A113

Nkoulou R A21

Noel D A105

Nolte M A180

Noordenbos T et al. Mast cells contribute to synovial inflammation in non-psoriatic and psoriatic spondyloarthritis, A41

Noort A-R et al. Nuclear factor-κB (NF-κB) inducing kinase is preferentially expressed in rheumatoid arthritis synovial tissue containing ectopic lymphoid neogenesis, A59, Nuclear factor-kappa B (NF-kappaB) inducing kinase is preferentially expressed in rheumatoid arthritis synovial tissue containing ectopic lymphoid neogenesis, A60

Norein SA A15

Novota P A76

Nowak B A127

Nur MAM A15

Nurmohamed MT A30

Oerum H A123

Oliveira ASF A110

Oliver Distler HW A64

Orphanos N A177

Ossipova E et al. Identification of specific citrullination sites on fibrinogen in RA, A4

Östberg T A90, A94

Ottosson C A133

Pagano S A21

Palmer G A148

Palotai R A181

Palumbo K A64

Panayi G A53

Panayi GS A144

Pap T A104, A49, A114, A43, A48, A104, A43, A114, A43, A114, A114

Papadopoulos G A71

Papendieck A A109

Paramarta JE A103

Parmar R A170, A172

Pasquali J-L A5

Pásztói M A3

Patakas A A42

Paterson E A23

Paul Emery A61

Pauley BA A22

Pavenstädt H A48

Pawlak D A174

Pena A A139

Pennings B A98

Pereira da Silva JA A166

Perpétuo IP A139

Perpétuo I A128

Perpétuo I et al. Influence of anti-tumour necrosis factor drugs, tocilizumab and methotrexate on osteoclast differentiation, A20, Tumour necrosis factor antagonists and tocilizumab have a higher impact on rheumatoid arthritis osteoclastogenic stimuli than methotrexate, A55

Pers J A105

Pers J-O A120, A105, A105, A34, A35

Pers Y-M A153

Pers YM et al. The microRNAs as biomarkers in knee osteoarthritis, A48

Peter Tak P A147

Peters MA A43, A43

Peters MA et al. Loss of integrin α2β1 reduces tumour necrosis factor-dependent inflammatory cartilage destruction and matrix metalloproteinase expression through modulating extracellular signal-regulated kinase, A22

Petraki E A89, A72

Petríková J et al. Prevalence of Toxoplasma antibodies among patients with various autoimmune diseases, A8

Philippe A A109

Pitzalis C A31

Pizzorni C A124

Plant D A71

Pohle S A113

Polgár A A3

Polido-Pereira J A128, A128, A130

Polzer K A42

Polzer K et al. Anti-interleukin 17A therapy inhibits tumour necrosis factor-mediated bone loss by modulation of T cell balance, A18

Ponchel F A170, A172

Ponikowska M A127

Pozsonyi E A3

Pratt AG et al. Peripheral blood CD4 T cell gene expression profiles as predictive biomarkers in early arthritis, A72

Presumey J A153

Presumey J et al. Negative regulation of BIK by the micro RNA-125b interferes with macrophage apoptosis in rheumatoid arthritis, A35

Proctor G A31

Prots I A189

Prots I et al. Molecular mechanisms of peripheral CD25 regulatory T cell (Treg) development, A70

Pruijn GJM A13

Pundt N A114, A43, A114

Purath U et al. Adoptive cellular gene therapy of autoimmune arthritis using a combination of lentivirally transduced dendritic cells, A59

Putova I A23

Putterman C A26

Queiroz MV A128

Radbruch A A132, A27, A79, A125, A164

Radstake TRDJ A75, A98, A95

Radtke H A132

Radzikowska A A174

Rajewsky N A164

Ram M A20

Ramirez J-M et al. Activation of the aryl hydrocarbon receptor in vivo primes human T cells for interleukin 22 production and inhibits Th17 cells, A74

Ramming A A189

Ramos MI et al. Fms-like tyrosine kinase 3 ligand (Flt3L) levels are elevated in RA synovial fluid, A43

Raposo BR et al. Disease amelioration in the K/BxN mouse model of spontaneous chronic arthritis after CD8 T cell depletion, A66

Raterman HG A30

Rath E A131

Rath E et al. Analysis of polymorphonuclear neutrophil (PMN) phenotype and function at the onset of collagen-induced arthritis, A51

Ratsimandresy R A116

Ravera F A124

Rawstron A A172

Reber G A21

Redlich K A169, A49, A126

Reedquist KA A168, A123, A123, A168, A41

Rehart S A137, A137

Reindl C A165

Remans P A147

Renaudineau Y et al. Endogenous retrovirus control is impaired in B cells from patients with systemic lupus erythematosus, A34, NFAT2 and STAT3 control type 2 cytokines in CD5 B cells, A14

Revu S et al. Methothrexate directly inhibits RANKL expression and osteoclast formation in very early arthritis, A23

Rhee L A80

Richardson S A184

Rieck M A185

Riemekasten G A109, A109

Riemekasten G et al. Systemic sclerosis as prototypic disease with high levels of functional antibodies against angiotensin II type-1 and endothelin-1 type A receptor strongly predicting prognosis, A5

Rittore C A83

Riveiro-Naveira R A143

Riveiro-Naveira RR A143

Robinson D A67

Rodière M A83

Rodrigues AM A128, A128

Rodrigues A A139, A130

Rodriguez E A148

Roeb E A62

Rojkovich B A3

Romano E A161

Rönnblom L A14

Rönnelid J A14, A15, A129

Roosnek E A188

Rosário HS A128, A128

Rose T A132

Rossier MF A21

Roth B et al. Cellular Factor XIII and peptidylarginine deiminase-catalysed citrullination in rheumatoid arthritis, A4

Roth J A102, A102

Rouquier S A179

Routsias JG et al. Structural insights into antigenicity of Ro/La ribonucleoprotein: SLE related epitopes are cryptic, masked by hY1 RNA, A3

Roux-Lombard P A21

Rovere-Querini P A1

Rudnicka W A174

Ruiz B A162

Rüther C A104

Saeland E A106

Salinas GF et al. TNFα blockade impairs T cell dependent humoural responses, A13

Salloum R et al. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon α activity in patients with systemic lupus erythematosus, A32

Sanders ME A168, A123, A168

Santegoets KCM A98, A95

Saraux A A105

Sármay G A2

Satoh M A22

Sattar N A101

Sattler A A132

Saurat J-H A188

Savitskaya A A131, A131

Scanzello CR A93

Schäfers M A48

Scharnert J A104

Scharstuhl A A98

Scheinecker C A131, A160, A131

Schelbergen R A102

Schelbergen RFP et al. Alarmins S100A8 and S100A9 skew chondrocytes towards a cartilage breakdown phenotype, A44

Scherer HU A121, A16

Scherman D A153

Schett G A29, A42, A29, A42, A91, A113, A1, A24, A53

Schierbeck H A94

Schierbeck H et al. Immunomodulatory drugs can inhibit the extracellular release of HMGB1 from cultured human monocytes, A36

Schmeiser T A62

Schmidt A A104

Schnaeker EM A49

Scholtysek C et al. NR4A1 modulates the inflammatory response during murine experimental arthritis, A37

Schramm M et al. Elevated expression of the Th17 cytokine interleukin 22 in rheumatoid arthritis, A65

Schreiyäck C A55

Schreurs M A30

Schubert K A129

Schulze-Koops H A165, A176, A165, A189

Schwab A A104

Scott JL et al. Complement activation and regulation in early and advanced stage osteoarthritis, A37

Screaton GR A171

Sebbag M A4, A5

Sebestyén Simon P A141

Seeuws S et al. A multiparameter approach to monitor disease activity in collagen-induced arthritis, A62

Sehnert B A24

Sehnert B et al. A Tissue-specific NF-κB inhibitor ameliorates inflammatory joint diseases, A45

SéitéJ-F A120

Selmi C A20

Semerano L A116

Sengler C A27

Senolt L A141

Senolt L et al. Metastasis-promoting protein S100A4 (MTS1) upregulates production of proinflammatory cytokines via TLR-4, A38

Serre G A4, A5

Shapira Y A20

Shapira Y A156

Shaw AS A108

Shields AM et al. Treatment of collagen-induced arthritis with lentiviral BiP improves clinical parameters of disease, A56

Shlomchik M A8

Shoenfeld Y A156, A20

Sidiropoulos P A71

Sidiropoulos P A89, A72

Sieper J A125

Sigridur Hreggvidsdottir H et al. Interleukin 1β and TLR ligands give enhanced cytokine production by their interaction with HMGB1, A38

Sikora E A100

Skapenko A A165, A176, A165, A189

S-Koops H A189

Skriner K A8

Sloetjes A A102, A102

Sloetjes AW A102

Slowinski T A109

Smiljanovic B et al. Defining TNFα-, IFNα- and IFNγ-induced gene expression profiles in human monocytes to estimate their cytokine-specific impact in inflammatory diseases, A32

Smolen J A169, A126, A151

Smolen JS A131, A160, A131

Snir O et al. Identification and function of T cells reactive with citrullinated vimentin in HLA-DRB1*0401 humanised mice and rheumatoid arthritis patients, A73

Sochnev A A100

Sohn J A108

Sokolik R et al. Early diagnostic Achilles tendinopathy in patients with psoriasis and arthralgia, A50

Soldano S et al. Modulation of gene expression by leflunomide and prednisone during treatment of early rheumatoid arthritis, A31

Soler S A83

Song GG A108

Song YW A114

Sorg O A188

Soulillou J-P A147

Sousa E A128, A128

Souto-Carneiro MM A128, A128, A166

Stagakis E et al. Micro RNA analysis reveals novel genes in human systemic lupus erythematosus: miR-21 affects PDCD4 expression and regulates aberrant T cell responses, A28

Steinbrich-Zöllner M et al. Ankylosing spondylitis: immunophenotypical characteristics of peripheral blood and synovial fluid compartments, A49

Steiner CW A151

Steiner C-W A131

Steiner G A151, A151, A8

Steinmeyer J A137, A137

Stenberg P A102

Stittrich A-B et al. MicroRNA-182 promotes clonal expansion of activated T helper cells, A65

Stoianovic-Susulic V A121

Stolarski B A73

Storm G A54

Stratis A A114

Stratis A et al. Antibodies against syndecan-4 reduce cartilage destruction in RA-like disease of hTNF transgenic mice, A45

Strietholt S A43, A43

Strietholt S et al. SUMO-specific protease 7 (SENP7) regulates matrix metalloproteinase-9 expression in synovial fibroblasts, A17

Stürz H A137, A137

Su L Profiling the T cell repertoire in rheumatoid arthritis, A75

Sulli A A124

Superti-Furga G A169

Suwannalai P et al. Anti-citrullinated protein antibodies have a low avidity compared to antibodies against recall-antigens, A7

Svensson CI A135

Swan DC A184

Szabó TG et al. Critical role of protein glycosylation in T cell immunity/autoimmunity, A71

Szarka E et al. Identification of a new citrullinated epitope on filaggrin for the early diagnosis of rheumatoid arthritis, A1

Szekanecz Z A156

Szyper-Kravitz M A156

Taams LS A182

Tak PP A115, A168, A103, A123, A180, A123, A81, A168, A103, A149, A110, A37, A41, A171, A103

Tak P-P A147

Talabot-Ayer D A148

Tarner IH A150

Tartelin M-L A178

Tas SW A149

Teitsma C A103

Teitsma CA A103

Tekstra J A37

Thiel A A132

Thompson SJ A144

Thümmler K et al. Immune regulation by peripheral Tregs induced upon homotypic T cell/T cell interactions, A74, Immune regulation by peripheral Tregs induced upon homotypic T cell/T cell interactions, A75

Thurlings RM et al. The relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis, A14

Tiersma Y A103

Tinazzi I et al. Differential pattern of expression of caveolin-1 and AIF-1 in chronic graft-versus-host disease suggests a specific role in the pathogenesis of systemic sclerosis, A24

Tincani A A22

Tobón GJ A105

Tobón GJ et al. Sjögren's syndrome (SS): are increased serum levels of cytokine FMS-like tyrosine kinase 3 ligand (Flt3L) indicative of lymphoma?, A14

Toes REM A187, A121, A16, A16, A121

Tokatly I A181

Tony Holden M A63

Tóthfalusi L A3, A181

Touitou I A83, A83

Toussa S A71

Trouw LA A121, A16

Tzioufas AG A7

Uderhardt S A91

Ujfalussy I A3

Umlauf D A104

Undeutsch R A109

Undeutsch R et al. Interleukin10-producing CD4 T cells ameliorate murine lupus in NZB/W F1 mice, A66

Unger W A106

Urbonaviciute V et al. HMGB1 containing nucleosomes from apoptotic cells induce inflammation and immune activation via TLR2 – implications for the etiopathogenesis of systemic lupus erythematosus, A1

Utset TO A80

Vaamonde-García C A143

Vaamonde-García C et al. Inflammatory response is modulated by mitochondrial dysfunction in cultured normal human chondrocytes, A15

Vacher-Lavenu MC A162

Valcárcel-Ares MN et al. A novel role for mitochondrial dysfunction in the inflammatory response of rheumatoid arthritis, A56

Valcarcel-Ares N A143

Vale M A139

Valentini G A161, A20

Valeria Riccieri A62

van Baarsen LG A37

van Bon L A95

van Bon L et al. Modulating TLR responses in systemic sclerosis via heme oxygenase-1, A39

van de Burg M A147

van de Geijn FE et al. Can mannose-binding lectin explain the course and outcome of pregnancy in rheumatoid arthritis?, A42

van de Loo FA A119

van de Loo FAJ A46

van de Sande GPM A123, A41

van de Sande M A103

van de Sande MGH A123

van de Sande MGH et al. The Ang-1/Tie2 angiogenic axis is selectively engaged in rheumatoid arthritis (RA) synovial tissue even before ACR criteria of RA are met, A28, Expression of Tie2 and Ang-1 is related to the development of persistent and erosive disease in patients with early arthritis, A28

van de Stadt LA et al. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in seropositive arthralgia patients, A6

van de Stadt RJ A13

van den Berg W A42, A98

van den Berg WB A46, A102, A119, A54, A119, A102, A102, A95

van der Horst A A13

van der Kraan PM A46

van der Pouw Kraan T A30

van der Voort EIH A187

van der Woude D A121, A16

van der Woude D et al. A gene–environment interaction between HLA SE alleles and smoking affects the reactivity of ACPA to various citrullinated antigens, A7

van Hamburg JP A173

van Hamburg JP et al. CCR6 Th17 but not CCR6 Th1 cells cooperate with synovial fibroblasts in a proinflammatory feedback loop in early rheumatoid arthritis, A72

van Kampen AHC A81

van Kooyk Y A106

van Lent PL A54

van Lent PLEM A102, A119, A102

van Lent PLEM et al. Alarmin S100A8 causes severe cartilage damage in antigen-induced arthritis through TLR4 activation and upregulation of FcɛRI and FcɛRIV, A41

Van Lier RA A180

van Maanen MA A123

van Osch GJVM A121

Van Praet J A157

van Riel PLCM A95

van Schaardenburg D A13

van Schaik BDC A81

van Tol MJ A16

van Vliet SJ A106

van Westing DM A37

van Zoest KPM A149

Vandeghinste N A157

Vasile M A62

Vassou D et al. Role of the pro-apoptotic pyrin-interacting protein Siva in the pathogenesis of familial mediterranean fever, A29

Vaz MF A139

Vazgiourakis V A71

Vencovsky J A141, A23, A76

Vencovský J A141

Venetia Bigley A63

Verbeek JS A123

Verduyn W A16

Verginis P A136, A177, A68

Vervoordeldonk MJ A115, A168, A123

Verweij C A30

Verweij CL A37

Vestweber D A113

Viana Queiroz M A128, A130

Viatte S A140

Vieira PL et al. Expansions of interleukin 21-secreting CD4 T helper cells in inflammatory arthritides, A68

Villaggio B A78

Villeneuve E A170

Vital E A170

Vital EM et al. High serum B cell activating factor predicts good clinical response to rituximab in RA: pilot data, A11

Vittecoq O A170

Vogl T A102, A102

Volgers C A95

Voll R A113

Voll RE A42, A29, A1, A24

Vonk M A98

Vonk MC A75

Vos K A37

Voskuyl A A30

Vosslamber S et al. IFN signature determines responder status on B cell depletion in rheumatoid arthritis patients, A12

Vreijling J A123

Vugler A A155

Vuilleumier N et al. Anti-apolipoprotein A-1 autoantibodies as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction, A8

Wagener F A98

Wagner H A1

Wähämaa H A90, A94

Walgreen B A54

Wanivenhaus A A160

Warnawin E A174

Weber CK et al. Antibodies to the endoplasmic reticulum-resident chaperones calnexin, BiP AND Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus, A10

Weenk M A95

Wehmeyer C A114

Wehmeyer C et al. The role of the Wnt inhibitor sclerostin in rheumatoid arthritis, A21

Weide T A48

Wendholt D A43, A114

Wenink MH A98

Wenink MH et al. β2 Integrins control the proinflammatory phenotype of type 1 macrophages and dendritic cells, A38

Wensveen FM A81

Wessels J A113

Wietelmann A A55

Wijbrandts CA A123, A41

Wiland P A127

Will C A49

Willemsen SP A107

Wilson G A184

Wipff J A162

Wixler V A49

Wolbink GJ A13

Wollheim F A102

Wolvers-Tettero ILM A75

Woo JH A108

Wooley PH A144

Wu P A125

Wuhrer M A107

Wunrau C A49, A43, A114

Wunrau C et al. Induction of death receptor ligand-independent apoptosis by endogeneous TIMP3 in mesenchymal cells, A18

Yaksh TL A135

Yazici A A77

Yeremenko N A103

Yeremenko N et al. Decreased soluble tumour necrosis factor expression in spondylarthritis versus rheumatoid arthritis synovitis, A57

Yilmaz-Elis AS A123

Yoo D-H A108

Youinou P A120, A105, A105, A34, A35

Young DA A184

Yusuf E et al. Immunological characterisation of Hoffa's fat pad in osteoarthritis, A48

Zagury D A116

Zagury JF A116

Zaiss M et al. Regulation of osteoclast differentiation and function by BiP, A21

Zaiss MM A29

Zampogna G A124

Zepa J A100

Zervou M A71

Zimmermann B A137

Zimmermann B et al. Migratory potential and influence on neoangiogenesis of rheumatoid arthritis synovial fibroblasts, A57

Zisappl M A156

Zwerina J A64

Zong M et al. Effect of immunosuppressive treatment on interleukin 15 in muscle tissue of patients, A52

Zubarev R A10

Zufferey P A140

Zuurmond A A121

Zwerina J A42, A42, A113

View Abstract

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.